BioStem Technologies, Inc.
BSEM
$3.88
-$0.08-1.92%
OTC PK
| 03/31/2026 | 09/30/2025 | 06/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 6.14M | 10.47M | -45.60M | -45.60M | 15.97M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.14M | 10.47M | -45.60M | -45.60M | 15.97M |
| Cost of Revenue | 2.38M | 1.20M | 685.20K | 685.20K | 853.40K |
| Gross Profit | 3.76M | 9.27M | -46.28M | -46.28M | 15.11M |
| SG&A Expenses | 10.97M | 5.80M | -48.41M | -48.41M | 8.12M |
| Depreciation & Amortization | 540.40K | 57.60K | 60.70K | 60.70K | 54.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.02M | 9.02M | -45.71M | -45.71M | 10.72M |
| Operating Income | -8.88M | 1.45M | 112.80K | 112.80K | 5.25M |
| Income Before Tax | -8.82M | 1.47M | 178.00K | 178.00K | 5.28M |
| Income Tax Expenses | -- | 707.70K | 742.30K | 742.30K | 1.37M |
| Earnings from Continuing Operations | -8.82M | 761.10K | -564.40K | -564.40K | 3.91M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.82M | 761.10K | -564.40K | -564.40K | 3.91M |
| EBIT | -8.88M | 1.45M | 112.80K | 112.80K | 5.25M |
| EBITDA | -8.34M | 1.51M | 173.50K | 173.50K | 5.30M |
| EPS Basic | -0.52 | 0.05 | -0.03 | -0.03 | 0.23 |
| Normalized Basic EPS | -0.33 | 0.05 | 0.01 | 0.01 | 0.20 |
| EPS Diluted | -0.52 | 0.03 | -0.03 | -0.03 | 0.15 |
| Normalized Diluted EPS | -0.33 | 0.04 | 0.01 | 0.01 | 0.13 |
| Average Basic Shares Outstanding | 16.85M | 16.75M | 16.71M | 16.71M | 16.67M |
| Average Diluted Shares Outstanding | 16.85M | 23.24M | 16.71M | 16.71M | 26.26M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |